Research Ideas and Outcomes : Conference Abstract
Print
Conference Abstract
Induced pluripotent stem (iPS) cells and somatic cardiac regeneration — An exploratory bioinformatic analysis
expand article infoRobert Jeenchen Chen‡,§, Yau-Hua Yu|
‡ Cardiovascular Surgery, Taipei Tzuchi Hospital, New Taipei City, Taiwan
§ Biochemistry & Molecular Biology, National Taiwan University College of Medicine, Taipei, Taiwan
| Periodontology, Tuft University School of Dental Medicine, Boston, MA, United States of America
Corresponding author: Robert Jeenchen Chen (rjcc@ntu.edu.tw)
Received: 11 Apr 2016 | Published: 14 Apr 2016
© 2016 Robert Jeenchen Chen, Yau-Hua Yu.
This is an open access article distributed under the terms of the Creative Commons Attribution License (CC BY 4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Citation: Chen R, Yu Y (2016) Induced pluripotent stem (iPS) cells and somatic cardiac regeneration— An exploratory bioinformatic analysis. Research Ideas and Outcomes 2: e8801. doi: 10.3897/rio.2.e8801
Open Access

Abstract

Background

Cardiac regeneration may be the future ultimate therapy for terminal heart failure. Nucleostemin (GNL3) plays a pivotal role in cardiac repair. Induced pluripotent stem (iPS) cells, induced by SOX2-OCT4-NANOG complex, may offer clues form regeneration. We would like to explore the interactions by bioinformatic approach. We identified the candidates that interacted with nucleostemin (GNL3), SOX2, OCT4 (POU5F1), and NANOG with NCBI online Entrez Gene and PubMed. The pathway networks were built with Ingenuity Pathway Analysis (IPA) 7.5 ®.

New information

In GNL3 network, molecules related to cardiovascular system development and function included CDKN2A, TP53 (tumor protein p53), ID3, NPM1, and IL2 (p=8.4e-4 ~ 9.9e-4 by right-tailed Fisher Exact Test). In canonical pathways, PPP2R5A involved in cardiac beta-adrenergic signaling and Fgf (fibroblast growth factor) involved in human embryonic stem cell pluripotency. Nucleostemin and iPS networks had two common molecules: Fgf and TP53. Nucleostemin and iPS have interactions via tumor protein P53 and fibroblast growth factor, which would require future research.

Keywords

induced pluripotent stem (iPS) cells, nucleostemin, Ingenuity Pathway Analysis

Presentation event

Gold Prize of the Best Presentation of the Young Investigator Award, the Biennial Congress of the Association of Thoracic and Cardiovascular Surgeons of Asia (ATCSA) (http://www.atcsa2009.org), Seoul, South Korea, 2009.

Objective

Although there are clinical advances in mechanical circulatory support devices and heart transplantation, the ultimate therapy for a failing heart may be cardiac regeneration from reprogrammed somatic cells or induced pluripotent stem cells, which avoids the pitfalls in ethics of embryonic cells, device anticoagulants, or immunosuppressants (Heilmann 2008, Mauritz et al. 2008, Narazaki et al. 2008, Passier et al. 2008, Sauer 2008, Schenke-Layland et al. 2008, Siepe et al. 2008, Tulloch et al. 2008). Prior studies found nucleostemin (GNL3) may play a pivotal role in cardiac repair (Tjwa and Dimmeler 2008, Siddiqi et al. 2008). On the other hand, SOX2-OCT4-NANOG complex, the ectopically induced transcription factors for induced pluripotent stem (iPS) cells, is the key to stem cell pluripotency (Cyranoski 2008, Mauritz et al. 2008, Narazaki et al. 2008, Tulloch et al. 2008). We would like to explore their interactions by bioinformatic approach for future molecular biologists (Yosef et al. 2008, Garg et al. 2008).

Methods

Literature review was done with NCBI online Entrez Gene and PubMed to identify the candidate molecules that may interact with nucleostemin (GNL3), SOX2, OCT4 (POU5F1), and NANOG (Mauritz et al. 2008, Schenke-Layland et al. 2008, Siddiqi et al. 2008, Tjwa and Dimmeler 2008, Tulloch et al. 2008, Yosef et al. 2008). Ingenuity Pathway Analysis (IPA) 7.5 ® was then used to build the pathway networks exploiting the interplays of interactions with GNL3 and SOX2-OCT4-NANOG. Functional analyses of pathophysiological processes as well as canonical pathways were conducted and integrated.

Results

Functional pathway networks were built for nucleostemin (GNL3), with the interactions with the iPS (SOX2-OCT4-NANOG) network in the subcellular level (Fig. 1​). In the GNL3 network, molecules related to cardiovascular system development and function were identified: CDKN2A, TP53 (tumor protein p53), ID3, NPM1, and IL2 (p=8.4e-4 ~ 9.9e-4 by right-tailed Fisher Exact Test). In canonical pathways, PPP2R5A involved in cardiac beta-adrenergic signaling and Fgf (fibroblast growth factor) involved in human embryonic stem cell pluripotency. Nucleostemin was found having interactions in common with NANOG of the iPS networks via two molecules: Fgf and TP53.

Figure 1.

Nucleostemin (GNL3) and iPS (SOX2-OCT4-NANOG) subcellular interaction network

Conclusion

In the exploratory analysis, the functional pathway networks of nucleostemin and iPS interact via TP53 (tumor protein P53) and Fgf (fibroblast growth factor), which could be further investigated to provide clues for the future research of postnatal cardiac regeneration (Huang et al. 2008).

Conflicts of interest

None.

References

login to comment